Sysmex Co. (OTCMKTS:SSMXY) Sees Large Decrease in Short Interest

kopsource ·  01/18/2023 06:01

Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the target of a significant decline in short interest in the month of December. As of December 30th, there was short interest totalling 6,800 shares, a decline of 81.2% from the December 15th total of 36,200 shares. Based on an average daily trading volume, of 86,800 shares, the short-interest ratio is presently 0.1 days.

Sysmex Trading Down 1.4 %

Shares of Sysmex stock traded down $0.43 on Tuesday, hitting $31.28. 29,300 shares of the company traded hands, compared to its average volume of 40,504. The company has a current ratio of 2.88, a quick ratio of 2.07 and a debt-to-equity ratio of 0.05. The company has a market cap of $13.12 billion, a PE ratio of 35.54 and a beta of 0.61. The stock's 50 day moving average price is $30.64 and its 200-day moving average price is $30.10. Sysmex has a 52 week low of $25.08 and a 52 week high of $52.01.

Get Sysmex alerts:

About Sysmex

(Get Rating)

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing.

Recommended Stories

  • Get a free copy of the research report on Sysmex (SSMXY)
  • United Airlines Soars Ahead of Earnings...Time to Deplane?
  • Is Dividend King PPG Industries A Buy Before Earnings?
  • Shocking New Documentary Exposes The Two Men Destroying America
  • 3 Dividend Stocks For Passive Income
  • UnitedHealth Group Stock: Is This The Bottom?

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment